Moderna, Inc. (MRNA) 今日盘中大涨5.15%，引起了投资者的广泛关注。
消息面上，欧盟法院顾问建议驳回欧盟执委会在新冠疫苗合同案中的上诉，维持要求披露有关新冠疫苗合同信息的原判。这一建议可能意味着疫苗合同的透明度将增加，对于作为主要新冠疫苗制造商的Moderna来说，被视为一个积极信号，增强了市场对其业务前景的信心。
Moderna, Inc. (MRNA) 今日盘中大涨5.15%，引起了投资者的广泛关注。
消息面上，欧盟法院顾问建议驳回欧盟执委会在新冠疫苗合同案中的上诉，维持要求披露有关新冠疫苗合同信息的原判。这一建议可能意味着疫苗合同的透明度将增加，对于作为主要新冠疫苗制造商的Moderna来说，被视为一个积极信号，增强了市场对其业务前景的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.